Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

27.61 +1.64 (+6.31%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,530,668
Open	25.96
Bid (Size)	25.50 (300)
Ask (Size)	29.33 (100)
Prev. Close	25.97
Today's Range	25.88 - 27.72
52wk Range	9.600 - 27.72
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Centessa Pharmaceuticals Stock Crushed the Market Today ↗

November 12, 2025

Investors were optimistic about the company potentially reaping $250 million in gross proceeds from an equity offering.

Via The Motley Fool

Neural Gold Rush: Is Brain Data the Most Precious Commodity of the Century?

November 12, 2025

As the digital age continues its relentless march, a new contender has emerged for the title of the world's most valuable commodity: neural data. Far surpassing traditional resources like oil or even...

Via MarketMinute

Performance

YTD	+57.8%	+57.8%
1 Month	+20.8%	+20.8%
3 Month	+57.0%	+57.0%
6 Month	+125.2%	+125.2%
1 Year	+72.6%	+72.6%

More News

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

November 11, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

November 11, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

November 07, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

Via Chartmill

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

November 05, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

This Domino's Pizza Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

October 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 20, 2025

Via Benzinga

CENTESSA PHARMACEUTICALS-ADR (NASDAQ:CNTA) Shows Strong Technical Setup for Potential Breakout ↗

October 17, 2025

Via Chartmill

3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores ↗

September 12, 2025

Via Benzinga

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

September 03, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

August 12, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives. ↗

July 21, 2025

Via Investor's Business Daily

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

June 16, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

May 19, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

May 14, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday ↗

May 08, 2025

Via Benzinga

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

March 24, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

March 06, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

AeroVironment Posts Downbeat Results, Joins Box, CrowdStrike And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 05, 2025

Via Benzinga

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

January 28, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2025

Via Benzinga

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

January 08, 2025

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 25, 2024

Via Benzinga

Frequently Asked Questions

Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?

Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.

What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?

Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?

The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market

What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?

The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 27.61

When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?

The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 11/14/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.